公司资料
Galera Therapeutics 股价、新闻与催化剂
- 股票代码:
- GRTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
17.60 USD (-2.22%)
收盘价
最后更新: 2026年7月10日
—
市值
股价为何变动
Current closing-price context is not available for GRTX.
公司概览
业务概览
Galera Therapeutics was a biotech company focused on oncology supportive care and radiation-related therapies before its restructuring and decline. Its legacy was centered on protecting patients during cancer treatment.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, Galera sat in specialty oncology biotechnology.
商业模式特征
The business depended on clinical development, regulatory steps, and the challenge of translating supportive-care science into a durable franchise.
生物医药行业定位
Galera belongs to the historical oncology-biotech group rather than the current live public-company set.
未来催化剂
- Galera is now largely a legacy and closeout story, so the catalysts are corporate resolution rather than a fresh pipeline readout. The market is focused on what value remains after the prior oncology effort.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。